No effect of risedronate on femoral periprosthetic bone loss following total hip arthroplasty: A 4-year follow-up of 61 patients in a double-blind, randomized placebo-controlled trial

BACKGROUND AND PURPOSE: We have previously shown that during the first 2 years after total hip arthroplasty (THA), periprosthetic bone resorption can be prevented by 6 months of risedronate therapy. This follow-up study investigated this effect at 4 years. PATIENTS AND METHODS: A single-center, doub...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Acta Orthop
Hauptverfasser: Muren, Olle, Akbarian, Ehsan, Salemyr, Mats, Bodén, Henrik, Eisler, Thomas, Stark, André, Sköldenberg, Olof
Format: Artigo
Sprache:Inglês
Veröffentlicht: Informa Healthcare 2015
Schlagworte:
Hip
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4564779/
https://ncbi.nlm.nih.gov/pubmed/25885280
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/17453674.2015.1041846
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge